{"id":"W2760883434","doi":"10.1007/s10549-017-4538-4","title":"A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.","year":2017,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Queen's University; Ottawa Hospital; Jewish General Hospital; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Oncolytics Biotech","keywords":"Medicine; Metastatic breast cancer; Clinical endpoint; Paclitaxel; Breast cancer; Internal medicine; Randomized controlled trial; Cancer; Interim analysis; Chemotherapy; Phases of clinical research; Oncology; Gastroenterology; Surgery; Urology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001731979,0.0003446741,0.001581572,0.001113548,0.0004016981,0.0000732484,0.0003596481,0.0000764671,0.0002551703],"category_scores_gemma":[0.00006631948,0.0001976744,0.0001476786,0.0008830367,0.0006507547,0.00002440667,0.0001097067,0.0001601613,2.587678e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003467271,"about_ca_system_score_gemma":0.00212846,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6698011,"about_ca_topic_score_gemma":0.948748,"domain_scores_codex":[0.9962131,0.001007237,0.0005740577,0.0006994283,0.0008088902,0.0006972889],"domain_scores_gemma":[0.9974696,0.0001027799,0.0004282587,0.0008421488,0.0007252961,0.0004319212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5937243,0.004002858,0.3544425,0.0000397804,0.01035232,0.00003077428,0.0006650452,0.0001114196,0.0006789776,0.000003179061,0.0000210423,0.03592778],"study_design_scores_gemma":[0.5950891,0.05312556,0.3437279,0.000260977,0.002731846,0.000008235401,0.001083619,0.0001907312,0.003262559,0.000009330448,0.00006393173,0.0004462844],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907429,0.001011782,0.000003351337,0.0004697611,0.00001644247,0.003186914,0.004538788,0.000002862482,0.00002725425],"genre_scores_gemma":[0.9950293,0.001940291,0.00003557875,0.00001184403,0.00004709388,0.002488024,0.0001514831,0.00003717097,0.0002592617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2789469,"threshold_uncertainty_score":0.806093,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0964503014945268,"score_gpt":0.4271501303381646,"score_spread":0.3306998288436378,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}